Initiation of coverage by Portzamparc

AMOEBA announces the initiation of coverage by Portzamparc – BNP Paribas Group

Chassieu (France), April 20, 2023 – 17h45 – AMOÉBA (FR0011051598 – ALMIB) an industrial biotech in pre-commercialization* specialized in the treatment of microbiological risk, developing a biocontrol agent for the treatment of plants in agriculture and a biological biocide for the treatment of industrial water, announces today that Portzamparc – BNP Paribas Group has initiated coverage on the company.

Portzamparc – BNP Paribas Group began its monitoring with a “Buy” recommendation and a study entitled: “the amoeba at the service of the environment”.Portzamparc ‘s study is available on Amoéba’s website in the “Shareholding / Coverage” section.